newsfilter
← Latest News
GlobeNewswire·

Qualigen Therapeutics, Inc. Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

CARLSBAD, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN, Inc.)), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential